Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries.
They do clinical trials for new drugs, including a recent trial for a neutralizing antibody for SARS-CoV-2 for the treatment and prevention of...
This is a Bullish indicator signaling MEDP's price could rise from here. Traders may explore going long the stock or buying call options. Tickeron's A.I. dvisor identified 44 similar cases where MEDP's MACD histogram became positive, and 35 of them led to successful outcomes. Odds of Success: 80%. Current price $118.57 crossed the support line at $117.33 and is...
Small trade may be attempted on NASDAQ:MEDP . Idea is that after yesterday's gap and strong rally during trading session, highly likely that gap is runaway gap. Such gap usually happen in the middle of the move, and thus price may target region ~90. Stop should be at the top edge of the gap at 74.27. Trade suggests around 2:1 in reward/risk potential.
Expecting the price would go slightly higher as well as RSI and forming bearish divergence signal for Elliott Wave 4 (EW4), which price shows HIGHER high, and RSI shows LOWER low.
My two cents.
Good luck!
MEDP seems running within an upward channel formation. Right now it's getting back from its upper Chanel line. It also has some 100% selles from insider. We think it has good downside potential.
To trade one could consider June $55 or $60 Puts
-------------------
*Trade Idea*
Date First Found- February 11, 2019
Pattern/Why- Upward Channel formation
Entry...
